The COVID-19 (coronavirus) pandemic threat is being addressed by all Australian Governments and health services.

People with diabetes may be concerned about their risk, and also the availability of insulin and other essential medicines and their National Diabetes Services Scheme (NDSS) products and supplies.

The Department of Health has advised Diabetes Australia that there are no current shortages or supply issues with insulin, diabetes medicines or NDSS products. People with diabetes are advised to order and obtain your diabetes medicines and supplies as usual. There is no need to stockpile.

The Australian Government plan to fight the COVID-19 threat includes provision of bulk-billed telehealth medical services, home medicine deliveries, support for additional aged care staff and increased service capacity for First Nations People in remote locations. Pharmacies with e-prescribing will be eligible to participate in the home medicines services.

New Medicare telehealth services will commence from Friday 13 March. Telehealth consultations will be provided by GPs and specialists, nurses and mental health allied health workers. They will be available under Medicare for people aged over 70, those with chronic conditions (including diabetes), First Nations People aged over 50, people who are immunocompromised, pregnant women and parents with new babies.

Diabetes Australia will continue to consult with the Australian Government and the Department of Health to ensure people with diabetes can access the latest information to help them stay safe and healthy during this time.

For more information visit the Australian Government’s Coronavirus Information Page. This page is updated regularly.

If you have questions about COVID-19 please call the Australian Government’s Coronavirus Health Information Line on 1800 020 080. The helpline operates 24 hours a day, seven days a week.

11 March 2019